 Michael Alberti
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abiotrophia | 2 | 2016 | 2 | 1.070 |
Why?
| | Carnobacteriaceae | 2 | 2016 | 3 | 1.070 |
Why?
| | Adenoviridae | 2 | 2012 | 185 | 0.780 |
Why?
| | Myeloid Cells | 2 | 2012 | 128 | 0.760 |
Why?
| | Genetic Therapy | 2 | 2012 | 258 | 0.730 |
Why?
| | Hematologic Neoplasms | 2 | 2021 | 136 | 0.720 |
Why?
| | Myeloproliferative Disorders | 1 | 2018 | 26 | 0.610 |
Why?
| | Gene Duplication | 1 | 2018 | 63 | 0.610 |
Why?
| | Genetic Vectors | 3 | 2014 | 291 | 0.580 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1477 | 0.550 |
Why?
| | Disk Diffusion Antimicrobial Tests | 1 | 2016 | 1 | 0.550 |
Why?
| | Luciferases, Renilla | 1 | 2015 | 4 | 0.510 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 19 | 0.510 |
Why?
| | Internal Ribosome Entry Sites | 1 | 2015 | 5 | 0.510 |
Why?
| | Virus Replication | 3 | 2015 | 395 | 0.500 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 441 | 0.500 |
Why?
| | Repressor Proteins | 1 | 2018 | 368 | 0.500 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 77 | 0.460 |
Why?
| | Drug Monitoring | 1 | 2014 | 184 | 0.430 |
Why?
| | Protein Biosynthesis | 1 | 2015 | 385 | 0.430 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 474 | 0.420 |
Why?
| | Viral Tropism | 1 | 2012 | 24 | 0.420 |
Why?
| | Gene Transfer Techniques | 2 | 2014 | 147 | 0.420 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1054 | 0.400 |
Why?
| | Splicing Factor U2AF | 2 | 2021 | 16 | 0.390 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1523 | 0.340 |
Why?
| | HIV-1 | 1 | 2015 | 768 | 0.340 |
Why?
| | Mutation | 2 | 2021 | 3354 | 0.320 |
Why?
| | Neoplasm Proteins | 2 | 2021 | 385 | 0.310 |
Why?
| | Peptide Fragments | 1 | 2012 | 668 | 0.300 |
Why?
| | Specimen Handling | 2 | 2019 | 156 | 0.270 |
Why?
| | RNA, Long Noncoding | 2 | 2017 | 154 | 0.230 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.220 |
Why?
| | B-Lymphocytes | 3 | 2021 | 772 | 0.210 |
Why?
| | Hepacivirus | 3 | 2010 | 229 | 0.200 |
Why?
| | Inflammation | 1 | 2012 | 2485 | 0.190 |
Why?
| | Genes, Reporter | 3 | 2021 | 257 | 0.190 |
Why?
| | Lymphopoiesis | 1 | 2021 | 24 | 0.190 |
Why?
| | Immunosuppressive Agents | 2 | 2016 | 648 | 0.190 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 215 | 0.190 |
Why?
| | Heterozygote | 1 | 2021 | 251 | 0.180 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 152 | 0.180 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 62 | 0.180 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 78 | 0.180 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 258 | 0.180 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 83 | 0.180 |
Why?
| | Myelodysplastic Syndromes | 1 | 2021 | 119 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2021 | 188 | 0.170 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 179 | 0.170 |
Why?
| | Leukemia | 1 | 2021 | 210 | 0.170 |
Why?
| | Pregnancy Complications | 1 | 2023 | 430 | 0.160 |
Why?
| | Alleles | 1 | 2021 | 791 | 0.160 |
Why?
| | 5' Untranslated Regions | 2 | 2010 | 51 | 0.160 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 94 | 0.150 |
Why?
| | Nucleic Acids | 1 | 2019 | 59 | 0.150 |
Why?
| | Artifacts | 1 | 2018 | 113 | 0.150 |
Why?
| | SOXC Transcription Factors | 1 | 2017 | 5 | 0.150 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2018 | 92 | 0.140 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 31 | 0.140 |
Why?
| | Humans | 18 | 2023 | 114937 | 0.140 |
Why?
| | Histones | 1 | 2021 | 536 | 0.140 |
Why?
| | Culture Media | 1 | 2016 | 155 | 0.130 |
Why?
| | Immunoassay | 1 | 2016 | 95 | 0.130 |
Why?
| | Molecular Typing | 1 | 2015 | 18 | 0.130 |
Why?
| | Transduction, Genetic | 2 | 2014 | 113 | 0.130 |
Why?
| | Los Angeles | 1 | 2015 | 56 | 0.130 |
Why?
| | beta-Lactams | 1 | 2015 | 27 | 0.130 |
Why?
| | HEK293 Cells | 2 | 2021 | 593 | 0.130 |
Why?
| | Tacrolimus | 1 | 2016 | 134 | 0.130 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 138 | 0.130 |
Why?
| | Hematopoietic Stem Cells | 2 | 2015 | 345 | 0.120 |
Why?
| | O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 5 | 0.120 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2015 | 61 | 0.120 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 64 | 0.120 |
Why?
| | Lentivirus | 1 | 2014 | 45 | 0.120 |
Why?
| | Blood Specimen Collection | 1 | 2014 | 32 | 0.120 |
Why?
| | Microbial Sensitivity Tests | 1 | 2015 | 301 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1355 | 0.110 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2015 | 174 | 0.110 |
Why?
| | Mice | 7 | 2021 | 14936 | 0.110 |
Why?
| | Prognosis | 2 | 2018 | 3344 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 486 | 0.110 |
Why?
| | Down-Regulation | 1 | 2015 | 596 | 0.110 |
Why?
| | Kupffer Cells | 1 | 2012 | 45 | 0.100 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 4719 | 0.100 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2012 | 135 | 0.100 |
Why?
| | Peptide Library | 1 | 2012 | 81 | 0.100 |
Why?
| | Hepatocytes | 1 | 2012 | 196 | 0.100 |
Why?
| | Bone Marrow Cells | 1 | 2012 | 267 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2017 | 536 | 0.090 |
Why?
| | Gene Expression | 1 | 2014 | 1422 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1151 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 966 | 0.080 |
Why?
| | Translocation, Genetic | 2 | 2021 | 94 | 0.080 |
Why?
| | Animals | 7 | 2021 | 31839 | 0.080 |
Why?
| | K562 Cells | 2 | 2021 | 73 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2012 | 1087 | 0.080 |
Why?
| | Hepatitis C | 1 | 2010 | 219 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2012 | 685 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2021 | 2725 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2021 | 2199 | 0.070 |
Why?
| | Virus Cultivation | 1 | 2006 | 25 | 0.070 |
Why?
| | Protein Binding | 1 | 2012 | 1897 | 0.070 |
Why?
| | Macrophages | 2 | 2010 | 1266 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2021 | 2587 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 1133 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1634 | 0.060 |
Why?
| | Gene Deletion | 1 | 2006 | 356 | 0.060 |
Why?
| | Hepatitis C, Chronic | 1 | 2006 | 151 | 0.060 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2023 | 525 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1749 | 0.050 |
Why?
| | Tumor Stem Cell Assay | 1 | 2021 | 33 | 0.050 |
Why?
| | Genetic Variation | 1 | 2006 | 876 | 0.050 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 76 | 0.050 |
Why?
| | RNA, Neoplasm | 1 | 2021 | 80 | 0.050 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 49 | 0.050 |
Why?
| | Transgenes | 1 | 2021 | 170 | 0.040 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2021 | 82 | 0.040 |
Why?
| | Lung | 1 | 2012 | 3593 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 701 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2019 | 21 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2019 | 27 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2791 | 0.040 |
Why?
| | Trans-Activators | 1 | 2021 | 368 | 0.040 |
Why?
| | Genetic Testing | 1 | 2021 | 379 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 544 | 0.040 |
Why?
| | Binding Sites | 1 | 2021 | 1176 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 576 | 0.040 |
Why?
| | YY1 Transcription Factor | 1 | 2017 | 27 | 0.040 |
Why?
| | Sp1 Transcription Factor | 1 | 2015 | 23 | 0.030 |
Why?
| | Gene Order | 1 | 2014 | 24 | 0.030 |
Why?
| | Phylogeny | 2 | 2010 | 795 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 299 | 0.030 |
Why?
| | Base Sequence | 2 | 2010 | 2118 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3008 | 0.030 |
Why?
| | Gene Dosage | 1 | 2014 | 134 | 0.030 |
Why?
| | Fluorouracil | 1 | 2014 | 152 | 0.030 |
Why?
| | Genotype | 2 | 2010 | 1775 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2102 | 0.030 |
Why?
| | RNA | 1 | 2019 | 810 | 0.030 |
Why?
| | Cell Survival | 1 | 2015 | 1022 | 0.030 |
Why?
| | DNA | 1 | 2019 | 1351 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1148 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1700 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 5527 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 728 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 325 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4525 | 0.020 |
Why?
| | RNA, Viral | 1 | 2006 | 566 | 0.010 |
Why?
| | Female | 2 | 2023 | 59581 | 0.010 |
Why?
| | United States | 1 | 2016 | 12211 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 3897 | 0.010 |
Why?
| | Child | 1 | 2017 | 18366 | 0.010 |
Why?
| | Time Factors | 1 | 2006 | 6125 | 0.010 |
Why?
| | Middle Aged | 1 | 2006 | 26806 | 0.000 |
Why?
|
|
Alberti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|